Y-Intercept (HK)’s Avadel Pharmaceuticals AVDL Stock Holding History

Y-Intercept (HK)’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-120,709	Closed	-$2.6M	–	1546
2025 Q4	$2.6M	Sell	120,709 -10,457	-8%	-$203K	0.06%	492
2025 Q3	$2M	Buy	131,166 +35,316	+37%	+$460K	0.05%	603
2025 Q2	$848K	Buy	+95,850	New	+$842K	0.02%	1010

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Y-Intercept (HK)'s AVDL Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 120,709 shares — an estimated $2.6M sold.

Y-Intercept (HK) first reported a position in AVDL in Q2 2025 and held it in 3 quarters. The position peaked at $2.6M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Y-Intercept (HK) reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Y-Intercept (HK) sold 120,709 Avadel Pharmaceuticals shares in Q1 2026, an estimated $2.6M.
Y-Intercept (HK) first reported a position in Avadel Pharmaceuticals in Q2 2025 and held it in 3 quarters.
Y-Intercept (HK)'s Avadel Pharmaceuticals position peaked at $2.6M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.